SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-15-018218
Filing Date
2015-05-07
Accepted
2015-05-07 16:12:22
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP 10-Q 3-31-2015 form10q.htm 10-Q 889324
2 EXHIBIT 10.3 ex10_3.htm EX-10.3 48007
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 9249
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 9351
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 8746
  Complete submission text file 0001140361-15-018218.txt   5923317

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rptp-20150331.xml EX-101.INS 711561
7 XBRL TAXONOMY EXTENSION SCHEMA rptp-20150331.xsd EX-101.SCH 39952
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20150331_cal.xml EX-101.CAL 54737
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20150331_def.xml EX-101.DEF 178657
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20150331_lab.xml EX-101.LAB 581364
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20150331_pre.xml EX-101.PRE 321954
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25571 | Film No.: 15841880
SIC: 2834 Pharmaceutical Preparations